Skip to main content
Erschienen in: The journal of nutrition, health & aging 3/2020

06.12.2019

Interleukin-1β Regulates Lipid Homeostasis in Human Glomerular Mesangial Cells

verfasst von: Hua Liu, Y. Deng, L. Wu, Y. Li, N. Lin, W. Li, X. Dong, Lina Ma

Erschienen in: The journal of nutrition, health & aging | Ausgabe 3/2020

Einloggen, um Zugang zu erhalten

Abstract

Background

Recent studies have shown that hyperlipidemia is closely related to the progression of kidney disease and glomerulosclerosis has similar pathophysiological mechanisms with atherosclerosis. Atherosclerosis is essentially a chronic inflammatory process and various kidney diseases are characterized by a micro-inflammatory state. Hyperlipidemia levels are not parallel to the degree of glomerulosclerosis, inflammatory factors together with lipids may contribute to the pathogenesis of glomerulosclerosis. Therefore, it is key to clarify lipid-mediated renal injury through studying the mechanism by which inflammation affects cholesterol homeostasis at the cellular level. Intracellular lipid homeostasis involves both lipid uptake and excretion, therefore in this study, we aimed to explore whether interleukin-1β (IL-1β) promotes the uptake of oxidized low-density lipoprotein (Ox-LDL) to increase in intracellular lipid levels, and to clarify the effect of IL-1β on the expression of lectin-like oxidized LDL receptor 1 (LOX-1) and ATP-binding cassette transporter A1 (ABCA1), which may regulate cholesterol homeostasis in human mesangial cells (HMCs).

Methods

The effect of IL-1β on uptake of Ox-LDL labeled with fluorescent Dil (Dil-Ox-LDL) by HMCs was observed using laser confocal microscopy. The effect of IL-1β on LOX-1 and ABCA1 expression in HMCs was detected by polymerase chain reaction and western blotting.

Results

Laser confocal microscopy revealed that HMCs took up Dil-Ox-LDL. Treatment of HMCs with 5 ng/ml IL-1β for 24 h significantly increased uptake of Dil-Ox-LDL. IL-1β also promoted LOX-1 mRNA and protein expression in a dose-dependent manner. Moreover, ABCA1 mRNA and protein expression were reduced by IL-1β in lipid-loaded HMCs in a dose-dependent manner.

Conclusions

IL-1β promotes the uptake of Ox-LDL and expression of LOX-1 in HMCs, whereas it inhibits expression of ABCA1 under lipid load. The imbalance in intracellular cholesterol resulted by IL-1β can in turn transform HMCs into foam cells and aggravate glomerulosclerosis.
Literatur
1.
Zurück zum Zitat Moorhead JF, Chan MK, EI-Nahas M, et a1. Lipid nephrotoxicity in chronic progressive glumerular and tubulointerstitial disease. Lancet, 1982, 2(8311): 1309–1311.CrossRef Moorhead JF, Chan MK, EI-Nahas M, et a1. Lipid nephrotoxicity in chronic progressive glumerular and tubulointerstitial disease. Lancet, 1982, 2(8311): 1309–1311.CrossRef
2.
Zurück zum Zitat Moorhead JF, Brunton C, Varghese Z. Glomerular atherosclerosis. Miner Electrolyte Metab, 1997, 23: 287–290.PubMed Moorhead JF, Brunton C, Varghese Z. Glomerular atherosclerosis. Miner Electrolyte Metab, 1997, 23: 287–290.PubMed
3.
Zurück zum Zitat Nasonov EL, Popkova TV. Atherosclerosis: perspectives of anti-inflammatory therapy. Ter Arkh. 2018, 90(5): 4–12.PubMed Nasonov EL, Popkova TV. Atherosclerosis: perspectives of anti-inflammatory therapy. Ter Arkh. 2018, 90(5): 4–12.PubMed
4.
Zurück zum Zitat Wanner C, Zimmermann J, Schwedler S, et al. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl, 2002,80:S99–S102.CrossRef Wanner C, Zimmermann J, Schwedler S, et al. Inflammation and cardiovascular risk in dialysis patients. Kidney Int Suppl, 2002,80:S99–S102.CrossRef
5.
Zurück zum Zitat Ruan XZ, Varghese Z, Powis SH, et al. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int, 2001, 60: 1716–1725.CrossRef Ruan XZ, Varghese Z, Powis SH, et al. Dysregulation of LDL receptor under the influence of inflammatory cytokines: a new pathway for foam cell formation. Kidney Int, 2001, 60: 1716–1725.CrossRef
6.
Zurück zum Zitat Oram JF, HDL apolipoproteins and ABCA1 partners in the removal of excess cellular cholesterol. Arteroscler Thromb Vasc Biol, 2003,23:720–727.CrossRef Oram JF, HDL apolipoproteins and ABCA1 partners in the removal of excess cellular cholesterol. Arteroscler Thromb Vasc Biol, 2003,23:720–727.CrossRef
7.
Zurück zum Zitat Morawietz H. LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis. Dtsch Med Wochenschr, 2010, 135:308–312.CrossRef Morawietz H. LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis. Dtsch Med Wochenschr, 2010, 135:308–312.CrossRef
8.
Zurück zum Zitat Fu R, Guo C, Wang S, et al. Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis. Arthritis Rheumatol, 2017, 69: 1636–1646.CrossRef Fu R, Guo C, Wang S, et al. Podocyte activation of NLRP3 inflammasomes contributes to the development of proteinuria in lupus nephritis. Arthritis Rheumatol, 2017, 69: 1636–1646.CrossRef
9.
Zurück zum Zitat Ruan XZ, Varghese Z, Moorhead JF, et al. Inflammation modifies lipid-mediated renal injury. Nephrol Dial Transplant, 2003, 18:27–32.CrossRef Ruan XZ, Varghese Z, Moorhead JF, et al. Inflammation modifies lipid-mediated renal injury. Nephrol Dial Transplant, 2003, 18:27–32.CrossRef
10.
Zurück zum Zitat Ruan XZ, Varghese Z, Powis SH, et al. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int, 1999, 56: 440–451.CrossRef Ruan XZ, Varghese Z, Powis SH, et al. Human mesangial cells express inducible macrophage scavenger receptor. Kidney Int, 1999, 56: 440–451.CrossRef
11.
Zurück zum Zitat Nagase M, Ando K, Nagase T, et al. Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium. Biochem Biophys Res Commun, 2001, 281: 720–725.CrossRef Nagase M, Ando K, Nagase T, et al. Redox-sensitive regulation of LOX-1 gene expression in vascular endothelium. Biochem Biophys Res Commun, 2001, 281: 720–725.CrossRef
12.
Zurück zum Zitat Li P, Zhang H, Sheng Z, et al. Role of LOX-1 in oxidized low-density lipoprotein induced expression of transforming growth factor-β 1 in human glomerular mesangial cells. Journal of China Medical University, 2007, 36(1): 23–26. Li P, Zhang H, Sheng Z, et al. Role of LOX-1 in oxidized low-density lipoprotein induced expression of transforming growth factor-β 1 in human glomerular mesangial cells. Journal of China Medical University, 2007, 36(1): 23–26.
13.
Zurück zum Zitat Kumaz O, Akadam-Teker AB, Yilmaz-Aydogan H, et al. The LOX-1 3′UTRl88CT polymorphism and coronary artery disease in Turkish patients. Mol Biol Rep, 2012, 39(4): 4351–4358.CrossRef Kumaz O, Akadam-Teker AB, Yilmaz-Aydogan H, et al. The LOX-1 3′UTRl88CT polymorphism and coronary artery disease in Turkish patients. Mol Biol Rep, 2012, 39(4): 4351–4358.CrossRef
14.
Zurück zum Zitat Ueno T, Kaname S, Takaichi K, et al. LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats. Hypertens Res, 2003, 26(1):117–122.CrossRef Ueno T, Kaname S, Takaichi K, et al. LOX-1, an oxidized low-density lipoprotein receptor, was upregulated in the kidneys of chronic renal failure rats. Hypertens Res, 2003, 26(1):117–122.CrossRef
15.
Zurück zum Zitat Yamamoto N, Toyoda M, Abe M, et al. Lectin-like oxidized LDL receptor-1(LOX-1) expression in the tubulointerstitial are likely plays an important role in human diabetic nephropathy. Intern Med, 2009, 48(4): 189–194.CrossRef Yamamoto N, Toyoda M, Abe M, et al. Lectin-like oxidized LDL receptor-1(LOX-1) expression in the tubulointerstitial are likely plays an important role in human diabetic nephropathy. Intern Med, 2009, 48(4): 189–194.CrossRef
16.
Zurück zum Zitat Du Y, Qian J, Song G, et al. Expression of LOX-1 in type 2 diabetic rat tubular interstitial tissues. Chinese Journal of Pathophysiology, 2013, 29(1): 50–55. Du Y, Qian J, Song G, et al. Expression of LOX-1 in type 2 diabetic rat tubular interstitial tissues. Chinese Journal of Pathophysiology, 2013, 29(1): 50–55.
17.
Zurück zum Zitat Jiang Z, Zhou R, Xu C, et al. Genetic valiation of the ATP-binding cassette transporter A1 and susceptibility to coronary heart disease. Mol Genet Metab, 2011, 103(1): 81–88.CrossRef Jiang Z, Zhou R, Xu C, et al. Genetic valiation of the ATP-binding cassette transporter A1 and susceptibility to coronary heart disease. Mol Genet Metab, 2011, 103(1): 81–88.CrossRef
18.
Zurück zum Zitat Attie AD, Kastelein JP, Hayden MR, Pivotal role of ABCAl in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res, 2001, 42:1717–1726.PubMed Attie AD, Kastelein JP, Hayden MR, Pivotal role of ABCAl in reverse cholesterol transport influencing HDL levels and susceptibility to atherosclerosis. J Lipid Res, 2001, 42:1717–1726.PubMed
19.
Zurück zum Zitat Wu J, Zhang Y, Wang N, et a1. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells. Am J Physiol Renal Physiol, 2004, 287:F886–F895.CrossRef Wu J, Zhang Y, Wang N, et a1. Liver X receptor-alpha mediates cholesterol efflux in glomerular mesangial cells. Am J Physiol Renal Physiol, 2004, 287:F886–F895.CrossRef
20.
Zurück zum Zitat Ruan XZ, Moorhead JF, Fernando R, et al. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol, 2003, 14:593–600.CrossRef Ruan XZ, Moorhead JF, Fernando R, et al. PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. J Am Soc Nephrol, 2003, 14:593–600.CrossRef
Metadaten
Titel
Interleukin-1β Regulates Lipid Homeostasis in Human Glomerular Mesangial Cells
verfasst von
Hua Liu
Y. Deng
L. Wu
Y. Li
N. Lin
W. Li
X. Dong
Lina Ma
Publikationsdatum
06.12.2019
Verlag
Springer Paris
Erschienen in
The journal of nutrition, health & aging / Ausgabe 3/2020
Print ISSN: 1279-7707
Elektronische ISSN: 1760-4788
DOI
https://doi.org/10.1007/s12603-019-1302-y

Weitere Artikel der Ausgabe 3/2020

The journal of nutrition, health & aging 3/2020 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.